Selected research
Market Structure
Global Single B Cell Antibody Screening Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Single B Cell Antibody Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Single B Cell Antibody Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Single B Cell Antibody Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Single B Cell Antibody Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Single B Cell Antibody Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Single B Cell Antibody Screening Service include Creative Biolabs, Curia, GenScript, Sino Biological,Inc., Shanghai Chempartner Lifescience Co., Ltd., Biointron Biological Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Beijing Biosynthesis Biotechnology Co., Ltd. and Automated Lab Solutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Single B Cell Antibody Screening Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Single B Cell Antibody Screening Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Single B Cell Antibody Screening Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Single B Cell Antibody Screening Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Single B Cell Antibody Screening Service Segment by Company
Creative Biolabs
Curia
GenScript
Sino Biological,Inc.
Shanghai Chempartner Lifescience Co., Ltd.
Biointron Biological Inc.
Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
Beijing Biosynthesis Biotechnology Co., Ltd.
Automated Lab Solutions
SAFE Pharmaceutical Technology Co., Ltd.
Nanjing Zoonbio Biotechnology Co., Ltd.
Single B Cell Antibody Screening Service Segment by Type
Customized Service
Functional Screening
Others
Single B Cell Antibody Screening Service Segment by Application
Drug Discovery
Biological Engineering
Clinical Diagnosis
Immune Research
Others
Single B Cell Antibody Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single B Cell Antibody Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Single B Cell Antibody Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single B Cell Antibody Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Single B Cell Antibody Screening Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single B Cell Antibody Screening Service industry.
Chapter 3: Detailed analysis of Single B Cell Antibody Screening Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Single B Cell Antibody Screening Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Customized Service
- Functional Screening
- Others
Applications
- Drug Discovery
- Biological Engineering
- Clinical Diagnosis
- Immune Research
- Others
Companies covered
- Creative Biolabs
- Curia
- GenScript
- Sino Biological,Inc.
- Shanghai Chempartner Lifescience Co., Ltd.
- Biointron Biological Inc.
- Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- Beijing Biosynthesis Biotechnology Co., Ltd.
- Automated Lab Solutions
- SAFE Pharmaceutical Technology Co., Ltd.
- Nanjing Zoonbio Biotechnology Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Single B Cell Antibody Screening Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Customized Service
- 1.2.3 Functional Screening
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Single B Cell Antibody Screening Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drug Discovery
- 1.3.3 Biological Engineering
- 1.3.4 Clinical Diagnosis
- 1.3.5 Immune Research
- 1.3.6 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Single B Cell Antibody Screening Service Growth Trends by Region
- 1.5.1 Global Single B Cell Antibody Screening Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Single B Cell Antibody Screening Service Market Size by Region (2021-2026)
- 1.5.3 Single B Cell Antibody Screening Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Single B Cell Antibody Screening Service Market Dynamics
- 2.1 Single B Cell Antibody Screening Service Industry Trends
- 2.2 Single B Cell Antibody Screening Service Industry Drivers
- 2.3 Single B Cell Antibody Screening Service Industry Opportunities and Challenges
- 2.4 Single B Cell Antibody Screening Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Single B Cell Antibody Screening Service Revenue by Company (2021-2026)
- 3.2 Global Single B Cell Antibody Screening Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Single B Cell Antibody Screening Service Key Company Head office and Area Served
- 3.4 Global Single B Cell Antibody Screening Service Company, Product Type & Application
- 3.5 Global Single B Cell Antibody Screening Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Single B Cell Antibody Screening Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Single B Cell Antibody Screening Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Single B Cell Antibody Screening Service Tier 1, Tier 2, and Tier 3
4 Single B Cell Antibody Screening Service Market by Type
- 4.1 Global Single B Cell Antibody Screening Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Single B Cell Antibody Screening Service Market Size by Type (2021-2032)
- 4.3 Global Single B Cell Antibody Screening Service Market Size Share by Type (2021-2032)
5 Single B Cell Antibody Screening Service Market by Application
- 5.1 Global Single B Cell Antibody Screening Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Single B Cell Antibody Screening Service Market Size by Application (2021-2032)
- 5.3 Global Single B Cell Antibody Screening Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Creative Biolabs
- 6.1.1 Creative Biolabs Company Information
- 6.1.2 Creative Biolabs Business Overview
- 6.1.3 Creative Biolabs Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Creative Biolabs Single B Cell Antibody Screening Service Product Portfolio
- 6.1.5 Creative Biolabs Recent Developments
- 6.2 Curia
- 6.2.1 Curia Company Information
- 6.2.2 Curia Business Overview
- 6.2.3 Curia Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Curia Single B Cell Antibody Screening Service Product Portfolio
- 6.2.5 Curia Recent Developments
- 6.3 GenScript
- 6.3.1 GenScript Company Information
- 6.3.2 GenScript Business Overview
- 6.3.3 GenScript Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GenScript Single B Cell Antibody Screening Service Product Portfolio
- 6.3.5 GenScript Recent Developments
- 6.4 Sino Biological,Inc.
- 6.4.1 Sino Biological,Inc. Company Information
- 6.4.2 Sino Biological,Inc. Business Overview
- 6.4.3 Sino Biological,Inc. Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Sino Biological,Inc. Single B Cell Antibody Screening Service Product Portfolio
- 6.4.5 Sino Biological,Inc. Recent Developments
- 6.5 Shanghai Chempartner Lifescience Co., Ltd.
- 6.5.1 Shanghai Chempartner Lifescience Co., Ltd. Company Information
- 6.5.2 Shanghai Chempartner Lifescience Co., Ltd. Business Overview
- 6.5.3 Shanghai Chempartner Lifescience Co., Ltd. Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Shanghai Chempartner Lifescience Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 6.5.5 Shanghai Chempartner Lifescience Co., Ltd. Recent Developments
- 6.6 Biointron Biological Inc.
- 6.6.1 Biointron Biological Inc. Company Information
- 6.6.2 Biointron Biological Inc. Business Overview
- 6.6.3 Biointron Biological Inc. Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Biointron Biological Inc. Single B Cell Antibody Screening Service Product Portfolio
- 6.6.5 Biointron Biological Inc. Recent Developments
- 6.7 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
- 6.7.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
- 6.7.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
- 6.7.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 6.7.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
- 6.8 Beijing Biosynthesis Biotechnology Co., Ltd.
- 6.8.1 Beijing Biosynthesis Biotechnology Co., Ltd. Company Information
- 6.8.2 Beijing Biosynthesis Biotechnology Co., Ltd. Business Overview
- 6.8.3 Beijing Biosynthesis Biotechnology Co., Ltd. Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Beijing Biosynthesis Biotechnology Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 6.8.5 Beijing Biosynthesis Biotechnology Co., Ltd. Recent Developments
- 6.9 Automated Lab Solutions
- 6.9.1 Automated Lab Solutions Company Information
- 6.9.2 Automated Lab Solutions Business Overview
- 6.9.3 Automated Lab Solutions Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Automated Lab Solutions Single B Cell Antibody Screening Service Product Portfolio
- 6.9.5 Automated Lab Solutions Recent Developments
- 6.10 SAFE Pharmaceutical Technology Co., Ltd.
- 6.10.1 SAFE Pharmaceutical Technology Co., Ltd. Company Information
- 6.10.2 SAFE Pharmaceutical Technology Co., Ltd. Business Overview
- 6.10.3 SAFE Pharmaceutical Technology Co., Ltd. Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 SAFE Pharmaceutical Technology Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 6.10.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments
- 6.11 Nanjing Zoonbio Biotechnology Co., Ltd.
- 6.11.1 Nanjing Zoonbio Biotechnology Co., Ltd. Company Information
- 6.11.2 Nanjing Zoonbio Biotechnology Co., Ltd. Business Overview
- 6.11.3 Nanjing Zoonbio Biotechnology Co., Ltd. Single B Cell Antibody Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Nanjing Zoonbio Biotechnology Co., Ltd. Single B Cell Antibody Screening Service Product Portfolio
- 6.11.5 Nanjing Zoonbio Biotechnology Co., Ltd. Recent Developments
7 North America
- 7.1 North America Single B Cell Antibody Screening Service Market Size (2021-2032)
- 7.2 North America Single B Cell Antibody Screening Service Market Size by Type
- 7.2.1 North America Single B Cell Antibody Screening Service Market Size by Type (2021-2026)
- 7.2.2 North America Single B Cell Antibody Screening Service Market Size by Type (2027-2032)
- 7.2.3 North America Single B Cell Antibody Screening Service Market Share by Type (2021-2032)
- 7.3 North America Single B Cell Antibody Screening Service Market Size by Application
- 7.3.1 North America Single B Cell Antibody Screening Service Market Size by Application (2021-2026)
- 7.3.2 North America Single B Cell Antibody Screening Service Market Size by Application (2027-2032)
- 7.3.3 North America Single B Cell Antibody Screening Service Market Share by Application (2021-2032)
- 7.4 North America Single B Cell Antibody Screening Service Market Size by Country
- 7.4.1 North America Single B Cell Antibody Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 7.4.3 North America Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 7.4.4 North America Single B Cell Antibody Screening Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Single B Cell Antibody Screening Service Market Size (2021-2032)
- 8.2 Europe Single B Cell Antibody Screening Service Market Size by Type
- 8.2.1 Europe Single B Cell Antibody Screening Service Market Size by Type (2021-2026)
- 8.2.2 Europe Single B Cell Antibody Screening Service Market Size by Type (2027-2032)
- 8.2.3 Europe Single B Cell Antibody Screening Service Market Share by Type (2021-2032)
- 8.3 Europe Single B Cell Antibody Screening Service Market Size by Application
- 8.3.1 Europe Single B Cell Antibody Screening Service Market Size by Application (2021-2026)
- 8.3.2 Europe Single B Cell Antibody Screening Service Market Size by Application (2027-2032)
- 8.3.3 Europe Single B Cell Antibody Screening Service Market Share by Application (2021-2032)
- 8.4 Europe Single B Cell Antibody Screening Service Market Size by Country
- 8.4.1 Europe Single B Cell Antibody Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 8.4.3 Europe Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 8.4.4 Europe Single B Cell Antibody Screening Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Single B Cell Antibody Screening Service Market Size (2021-2032)
- 9.2 China Single B Cell Antibody Screening Service Market Size by Type
- 9.2.1 China Single B Cell Antibody Screening Service Market Size by Type (2021-2026)
- 9.2.2 China Single B Cell Antibody Screening Service Market Size by Type (2027-2032)
- 9.2.3 China Single B Cell Antibody Screening Service Market Share by Type (2021-2032)
- 9.3 China Single B Cell Antibody Screening Service Market Size by Application
- 9.3.1 China Single B Cell Antibody Screening Service Market Size by Application (2021-2026)
- 9.3.2 China Single B Cell Antibody Screening Service Market Size by Application (2027-2032)
- 9.3.3 China Single B Cell Antibody Screening Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Single B Cell Antibody Screening Service Market Size (2021-2032)
- 10.2 Asia Single B Cell Antibody Screening Service Market Size by Type
- 10.2.1 Asia Single B Cell Antibody Screening Service Market Size by Type (2021-2026)
- 10.2.2 Asia Single B Cell Antibody Screening Service Market Size by Type (2027-2032)
- 10.2.3 Asia Single B Cell Antibody Screening Service Market Share by Type (2021-2032)
- 10.3 Asia Single B Cell Antibody Screening Service Market Size by Application
- 10.3.1 Asia Single B Cell Antibody Screening Service Market Size by Application (2021-2026)
- 10.3.2 Asia Single B Cell Antibody Screening Service Market Size by Application (2027-2032)
- 10.3.3 Asia Single B Cell Antibody Screening Service Market Share by Application (2021-2032)
- 10.4 Asia Single B Cell Antibody Screening Service Market Size by Country
- 10.4.1 Asia Single B Cell Antibody Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 10.4.3 Asia Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 10.4.4 Asia Single B Cell Antibody Screening Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Single B Cell Antibody Screening Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst